EPISODE · Dec 10, 2020 · 32 MIN
CVS Health CEO; “10,000 staffers are ready to vaccinate” & Starbucks’ 2021 Rebound
from Squawk Pod · host CNBC
The Food and Drug Administration votes today on whether to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use. CVS Health Chief Executive Larry Merlo said the company is ready to administer “vaccines into the arms of some of our most vulnerable populations” within 24 to 48 hours upon receiving its share of Covid-19 vaccines. Starbucks lost billions of dollars in sales this year due to the coronavirus pandemic, but sales in the United States and China have been rebounding faster than expected. Starbucks CEO Kevin Johnson discussed the company’s projections for 2021 as hopes rise over a coronavirus vaccine becoming available to the general public. Plus, consumers’ holiday spending plans in data from CNBC’s All America Economic Survey. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
The Food and Drug Administration votes today on whether to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use. CVS Health Chief Executive Larry Merlo said the company is ready to administer “vaccines into the arms of some of our most vulnerable populations” within 24 to 48 hours upon receiving its share of Covid-19 vaccines. Starbucks lost billions of dollars in sales this year due to the coronavirus pandemic, but sales in the United States and China have been rebounding faster than expected. Starbucks CEO Kevin Johnson discussed the company’s projections for 2021 as hopes rise over a coronavirus vaccine becoming available to the general public. Plus, consumers’ holiday spending plans in data from CNBC’s All America Economic Survey.
NOW PLAYING
CVS Health CEO; “10,000 staffers are ready to vaccinate” & Starbucks’ 2021 Rebound
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.